Literature DB >> 34508432

Low Cluster of Differentiation 4+ T Cell Count in People Living with HIV/AIDS Undergoing Antiretroviral Therapy Visiting a Reference Laboratory: A Descriptive Cross-sectional Study.

Samikshya Kandel1, Sundar Khadka2, Mahesh Lamsal3, Bimlesh Jha2, Sunil Paudyal2, Swotantra Gautam4, Sagar Poudel5, Mukunda Sharma2, Jeena Amatya6.   

Abstract

INTRODUCTION: Human Immunodeficiency Virus is a lentivirus that causes human immunodeficiency virus infection and over time, acquired immunodeficiency syndrome. Cluster of Differentiation 4+ T cell count of people living with this infection play a vital role to determine infection progression and necessary treatment changes. This study was conducted to find out the prevalence of low Cluster of Differentiation 4+ T Cell Count in the People Living with human immunodeficiency virus/ acquired immunodeficiency syndrome.
METHODS: A descriptive cross-sectional study was conducted between June to August 2018 in the Human Immunodeficiency virus and Hepatitis Reference Unit of National Public Health Laboratory, Ministry of Health and Population Teku. Ethical approval was taken (Reference Number 2912) and a total of 550 seropositive cases of Human Immunodeficiency Virus-1 undergoing antiretroviral therapy were studied. Convenient sampling technique was used. Data was analysed by Statistical Package for the Social Sciences.
RESULTS: Seventeen (3.1%) of patients had Cluster of Differentiation 4+ T cell counts below 100 cells/mm3 of blood. The mean Cluster of Differentiation 4+ T cell count was 509.3 cells/mm3 of blood. Of the total samples, 280 (50.9%) were males, 268 (48.7%) were females, and the rest 2 (0.4%) were of other gender.
CONCLUSIONS: Majority of people living with human immunodeficiency virus/ acquired immunodeficiency syndrome were found immune-competent.

Entities:  

Mesh:

Year:  2021        PMID: 34508432      PMCID: PMC8673451          DOI: 10.31729/jnma.6062

Source DB:  PubMed          Journal:  JNMA J Nepal Med Assoc        ISSN: 0028-2715            Impact factor:   0.406


  11 in total

1.  HIV infection, antiretroviral therapy, and CD4+ cell count distributions in African populations.

Authors:  Brian G Williams; Eline L Korenromp; Eleanor Gouws; George P Schmid; Bertran Auvert; Christopher Dye
Journal:  J Infect Dis       Date:  2006-10-03       Impact factor: 5.226

Review 2.  Immune activation and HIV persistence: implications for curative approaches to HIV infection.

Authors:  Nichole R Klatt; Nicolas Chomont; Daniel C Douek; Steven G Deeks
Journal:  Immunol Rev       Date:  2013-07       Impact factor: 12.988

3.  Seroprevalence of hepatitis B virus and hepatitis C virus co-infection among people living with HIV/AIDS visiting antiretroviral therapy centres in Nepal: a first nationally representative study.

Authors:  G Ionita; A Malviya; R Rajbhandari; W William Schluter; G Sharma; S Kakchapati; S Rijal; S Dixit
Journal:  Int J Infect Dis       Date:  2017-05-05       Impact factor: 3.623

4.  Correlates of HIV Infection Among Sexually Active Adults in Kenya: A National Population-Based Survey.

Authors:  Tom Oluoch; Ibrahim Mohammed; Rebecca Bunnell; Reinhard Kaiser; Andrea A Kim; Anthony Gichangi; Mary Mwangi; Sufia Dadabhai; Lawrence Marum; Alloys Orago; Jonathan Mermin
Journal:  Open AIDS J       Date:  2011-12-30

5.  HBV and HCV Coinfection among HIV/AIDS Patients in the National Hospital of Tropical Diseases, Vietnam.

Authors:  Bùi Vũ Huy; Kanxay Vernavong; Nguyễn Văn Kính
Journal:  AIDS Res Treat       Date:  2014-12-08

6.  Immunological and virological characterization of HIV-1 viremia controllers in the North Region of Brazil.

Authors:  Samara Tatielle M Gomes; Érica R Gomes; Mike B Dos Santos; Sandra S Lima; Maria Alice F Queiroz; Luiz Fernando A Machado; Izaura M V Cayres-Vallinoto; Antonio Carlos R Vallinoto; Marluísa de O Guimarães Ishak; Ricardo Ishak
Journal:  BMC Infect Dis       Date:  2017-06-01       Impact factor: 3.090

7.  Adherence to antiretroviral treatment and associated factors among people living with HIV and AIDS in CHITWAN, Nepal.

Authors:  Sujan Neupane; Govinda Prasad Dhungana; Harish Chandra Ghimire
Journal:  BMC Public Health       Date:  2019-06-10       Impact factor: 3.295

8.  Stigma trajectories among people living with HIV (PLHIV) embarking on a life time journey with antiretroviral drugs in Jinja, Uganda.

Authors:  Martin Mbonye; Sarah Nakamanya; Josephine Birungi; Rachel King; Janet Seeley; Shabbar Jaffar
Journal:  BMC Public Health       Date:  2013-09-05       Impact factor: 3.295

9.  The physical and psychological effects of HIV infection and its treatment on perinatally HIV-infected children.

Authors:  Rachel C Vreeman; Michael L Scanlon; Megan S McHenry; Winstone M Nyandiko
Journal:  J Int AIDS Soc       Date:  2015-12-02       Impact factor: 5.396

10.  Virological and Immunological Status of the People Living with HIV/AIDS Undergoing ART Treatment in Nepal.

Authors:  Chet Raj Ojha; Geeta Shakya; Shyam Prakash Dumre
Journal:  Biomed Res Int       Date:  2016-07-28       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.